论文信息 - Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose - 字舞流文

Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose

T. Schall | S. Miao | J. Jaén | P. Bekker | D. Dairaghi | J. Powers | L. Ertl | Yu Wang | L. Seitz | P. Zhang | D. Johnson | Dave Johnson | Penglie Zhang | A. Pennell | Y. Zeng | Yibin Zeng | Y. Wang | DJ Dairaghi | LC Seitz | LS Ertl | JP Powers | AM Pennell | T. Schall | JC Jaen